The Food and Drug Administration (FDA) has imposed restrictions on the prescription of drugs containing montelukast for people with allergic rhinitis, ruling that such medications should only be prescribed after other drugs have been used and failed to be effective.
Drugs containing montelukast could affect a person’s mental health while they are taking the medication or after treatment has stopped, with side effects including changes in behavior, unusual movements or suicidal thoughts, the FDA said in a statement yesterday.
Hung Kuo-teng (洪國登), head of the FDA’s Medicinal Products Division, told reporters that there are 31 drug permit licenses that have been issued in Taiwan for medications containing montelukast, which is used to treat asthma and allergic rhinitis, a type of nasal inflammation that occurs when the immune system overreacts to allergens in the air.
Citing National Health Insurance data, Hung said that each year, about 900,000 prescriptions of medication containing montelukast are given out.
Last year, the US Food and Drug Administration issued a warning against drugs containing montelukast, saying that their clinical effectiveness was not shown to be greater than the potential risk they posed to people’s mental health.
It then determined that they should not be used until other medications for allergic rhinitis have been used and found to be ineffective, Hung said.
In light of the warning, Taiwan’s FDA re-evaluated the effectiveness and risk of such medications, and its drug safety assessment panel determined that while drugs containing montelukast are effective in treating allergic rhinitis, they might also cause people to develop mental health problems, Hung said.
As a result, the agency has decided to list those medications as “rear-line” drugs, meaning that they can only be prescribed when other medications for nasal inflammation caused by allergies have failed to be effective, Hung said, adding that there are other drugs for treating asthma.
The ruling went into effect immediately.
The companies that hold permit licenses for drugs containing montelukast have been told to change the content of their package inserts before July 31 so that they state that the drugs can only be used when other medications for allergic rhinitis have failed to be effective, Hung said.
Companies that fail to make the change before the deadline would have their drug permit license revoked, Hung said.
Taiwanese can file complaints with the Tourism Administration to report travel agencies if their activities caused termination of a person’s citizenship, Mainland Affairs Council Minister Chiu Chui-cheng (邱垂正) said yesterday, after a podcaster highlighted a case in which a person’s citizenship was canceled for receiving a single-use Chinese passport to enter Russia. The council is aware of incidents in which people who signed up through Chinese travel agencies for tours of Russia were told they could obtain Russian visas and fast-track border clearance, Chiu told reporters on the sidelines of an event in Taipei. However, the travel agencies actually applied
Japanese footwear brand Onitsuka Tiger today issued a public apology and said it has suspended an employee amid allegations that the staff member discriminated against a Vietnamese customer at its Taipei 101 store. Posting on the social media platform Threads yesterday, a user said that an employee at the store said that “those shoes are very expensive” when her friend, who is a migrant worker from Vietnam, asked for assistance. The employee then ignored her until she asked again, to which she replied: "We don't have a size 37." The post had amassed nearly 26,000 likes and 916 comments as of this
New measures aimed at making Taiwan more attractive to foreign professionals came into effect this month, the National Development Council said yesterday. Among the changes, international students at Taiwanese universities would be able to work in Taiwan without a work permit in the two years after they graduate, explainer materials provided by the council said. In addition, foreign nationals who graduated from one of the world’s top 200 universities within the past five years can also apply for a two-year open work permit. Previously, those graduates would have needed to apply for a work permit using point-based criteria or have a Taiwanese company
US President Donald Trump said "it’s up to" Chinese President Xi Jinping (習近平) what China does on Taiwan, but that he would be "very unhappy" with a change in the "status quo," the New York Times said in an interview published yesterday. Xi "considers it to be a part of China, and that’s up to him what he’s going to be doing," Trump told the newspaper on Wednesday. "But I’ve expressed to him that I would be very unhappy if he did that, and I don’t think he’ll do that," he added. "I hope he doesn’t do that." Trump made the comments in
RSS